KIT/PDGFRA-IN-2
KIT/PDGFRA-IN-2 is a tyrosine kinase inhibitor targeting KIT and PDGFRA. KIT/PDGFRA-IN-2 inhibits the downstream signaling pathways of PDGFRA mutants, including the phosphorylation of AKT, MAPK and S6. KIT/PDGFRA-IN-2 can be used in the research of gastrointestinal stromal tumors.
For research use only. We do not sell to patients.
- Formula: C25H26FN7O2
- Molecular Weight:475.52
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
In Vitro
KIT/PDGFRA-IN-2 is a highly potent and selective inhibitor that achieves sub-nanomolar activity against PDGFRA-D842V and 37 nM activity against the PDGFRA-G680R solvent-front mutant[1].
KIT/PDGFRA-IN-2 (2-3-fold molar excess; 3 h) adopts a preorganized optimal binding conformation that fits well within the ATP-binding pocket of PDGFRAG680R without the need for significant structural rearrangement of either the inhibitor or the mutant kinase[1].
KIT/PDGFRA-IN-2 (5 µM; 20 h) displays a highly improved phenotypic selectivity profile relative to Avapritinib in non-target U2OS cells, inducing minimal off-target cellular morphological perturbations that predict reduced likelihood of undesired systemic toxicity[1].
KIT/PDGFRA-IN-2 (compound 45) (8 distinct concentrations across the test range) exerts potent growth inhibitory activity in PDGFRA-D842V mutant GIST cells at 10 nM, and is the most effective reported inhibitor against the Avapritinib (HY-101561)-resistant PDGFRA-D842V/G680R double mutant, achieving sub-micromolar GR50 values below 1000 nM[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
Chemical Information
-
Molecular Weight 475.52
-
Formula C25H26FN7O2
-
SMILES
OC1=CC2=C(N3CCN(C4=NC=C([C@](C5=CC=C(F)C=C5)(N)C)C=N4)CC3)N=CN=C2C=C1OC
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Kinase activity and phosphorylation assays
Kinase activity assays measure the ability of kinases to transfer phosphate groups from ATP to specific substrates, while phosphorylation assays detect the presence and levels of phosphorylated proteins. Common methods include radiolabeled ATP incorporation (e. g. ,), ADP release detection via bioluminescence (e. g. ,[3]), enzyme-linked immunosorbent assays (ELISA) for phospho-specific epitopes (e. g. ,[6]), and microtiter-based formats for high-throughput screening (e. g. ,[8]). The ADP-Glo assay quantifies kinase activity by measuring ADP produced during phosphorylation using a luciferase-based system. Radiometric assays involve autoradiography or scintillation counting after incorporation of 32P-labeled ATP into substrate proteins. ELISA-based approaches rely on phospho-specific antibodies to detect activated kinases in cell lysates or purified samples.
-
Western Blot
Western blotting (WB) is a commonly used experimental method in molecular biology, biochemistry, and immunogenetics for identifying and quantifying target proteins. It combines gel electrophoresis with immunoassay, enabling researchers to analyze protein expression, post-translational modifications, and molecular weight.
-
Protocol for Kinase activity and phosphorylation assays
Kinase activity assays measure transfer of phosphate from ATP to a protein or peptide substrate, generating phosphorylated substrate, ADP, or incorporated radiolabeled phosphate as the readout; phosphorylation assays measure site-specific phosphorylation in cells or tissues as a proxy for kinase-pathway activation, inhibition, or substrate regulation. Phosphorylation can be detected by phospho-specific Western blot, immunoprecipitation kinase assay, phospho-immunofluorescence, phospho-flow cytometry, luminescent ADP detection, radiolabeled ATP incorporation, or reporter-based pathway assays, and these readouts can be applied to cancer cells, primary neurons, mouse tumors, organoids, inflammatory macrophages, ferroptosis studies, and mitophagy studies when the kinase target is biologically relevant.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)